A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis.
about
Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenEffect of vitamin D on bone mineral density of elderly patients with osteoporosis responding poorly to bisphosphonatesCalcium intake and bone mineral density: systematic review and meta-analysisThe effect of strength training combined with bisphosphonate (etidronate) therapy on bone mineral, lean tissue, and fat mass in postmenopausal women.Loss of life years after a hip fracture.Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date.Progesterone and bone: actions promoting bone health in women.Treating postmenopausal osteoporosis in women at increased risk of fracture - critical appraisal of bazedoxifene: a reviewThe evidence for efficacy of osteoporosis treatment in men with primary osteoporosis: a systematic review and meta-analysis of antiresorptive and anabolic treatment in men.Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoidsUtilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based AnalysisEtidronate does not suppress periprosthetic bone loss following cemented hip arthroplasty.Canadian Consensus Conference on osteoporosis, 2006 update.Treating osteoporosis: economic aspects of bisphosphonate therapy.Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate.Use of bisphosphonates in the management of postmenopausal osteoporosis.Effects of increasing age, dosage, and duration of PTH treatment on BMD increase--a meta-analysis.Should we prescribe calcium or vitamin D supplements to treat or prevent osteoporosis?The efficacy and safety of vertebral fracture prevention therapies in post-menopausal osteoporosis treatment: Which therapies work best? a network meta-analysis.Long-term use of bisphosphonates in osteoporosis.Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies.The effectiveness of intermittent rat parathyroid hormone (1-34) treatment on low bone mass due to oestrogen or androgen depletion in skeletally mature rats
P2860
Q24242665-27790FCB-B82A-4C1A-8E44-1B3F1B2FE3E2Q24802074-C83AC1D0-B225-43EF-9419-E6E59AC21061Q26784337-66FE26E3-78A3-45C2-A5DE-2029C1BB8A09Q33185235-7E4F6C10-CD32-424C-8FF1-BE7352F8D2FEQ33660935-26863FB4-6A4D-4E38-9A3D-AA150556DAB7Q33788945-865AA810-8242-47EF-892C-059EAD8445F3Q34261512-9016047B-9268-4817-8591-E0C3FF9031EFQ34271979-6D4B0A8F-B08E-4227-A8F6-9450C96BA3DCQ35110262-2DCDE448-690C-4944-BAF2-E313464DF086Q35536952-D520DAE3-E64B-4282-BFF5-B88AF2A12524Q36045845-7BA1AABB-24FD-4C06-B578-2EB302BB746AQ36440568-5D34A96D-9B01-4C75-84D7-AC00C2CAA88AQ36454421-A72FAE6F-B664-48D8-B8FB-05E2361EB7CBQ36543142-818F7530-02B5-4E6A-A7B7-CF8B0965152BQ36979311-990A9838-52AC-44A5-9C5F-5A757CFF5EE3Q37800181-9DBD3BDE-E59B-4210-95F5-3C97950D15EEQ37975163-33264903-E134-4FCB-B4B9-D1D471756830Q38609024-0A2D4FE6-EFB9-4481-8D2C-31EA6FC94671Q41204558-DE8D7063-DF90-4EE6-BAA2-2F125D397D68Q43267062-1A4E8010-025D-4BD9-B273-02B3A4CB3300Q44429750-3EFFE29E-39EC-4048-A965-8C5073DBFF59Q58294828-EE083D02-BDF4-4111-AD14-E658FAF299BC
P2860
A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis.
@ast
A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis.
@en
A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis.
@nl
type
label
A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis.
@ast
A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis.
@en
A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis.
@nl
prefLabel
A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis.
@ast
A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis.
@en
A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis.
@nl
P2093
P356
P1476
A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis.
@en
P2093
J D Adachi
L Griffith
N Krolicki
Osteoporosis Research Advisory Group (ORAG)
P2888
P304
P356
10.1007/S001980170147
P407
P577
2001-01-01T00:00:00Z